Acne and its treatment;Akne und ihre behandlungsmoglichkeiten

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 41, 1999, Pages 1496-1503

  Boni R ^a   Hafner, J ^a   Krasovec, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Acne; Antibiotics; Retinoids; Treatment

Indexed keywords

ANTIANDROGEN; ISOTRETINOIN; ANTIINFECTIVE AGENT;

ACNE; ANTIBIOTIC RESISTANCE; ARTICLE; HUMAN; PATHOGENESIS; PROPIONIBACTERIUM ACNES; ACNE VULGARIS; BACTERIAL INFECTION; REVIEW;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PROPIONIBACTERIUM ACNES;

EID: 0033576038     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Leyden JJ, Nordstrom KM, McGinley KJ. Cutaneous microbiology. In: Goldsmith LA, editor. Physiology, Biochemistry, and Molecular Biology of the Skin. Oxford, New York: Lippincott;1991. p. 1403-24.
2. Hay JB, Hodgkins MB. Metabolism of androgens by human skin in acne. Br J Dermatol 1974;91:123-33.
3. Cunliffe WJ. Natural history of acne. In: Plewisg G, Marks R, editors. Acne and related disorders. London: Martin Dunitz; 1989:4-6.
4. Gonzales T, Gantes M, Bustabab S. Acne fulminans associated with arthritis in monozygotic twins. J Rheumatol 1985;12:189-91.
5. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J 1979;1:1109-10.
6. Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997;136:66-70.
7. Vexiau P, Husson C, Hivot M, Brevault JL, Fiet J, Julien R, et al. Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J Invest Dermatol 1990;94:279-83.
8. Neuberger M, Kundi M, Jager R. Chloracne and morbidity after dioxin exposure. Toxicol Lett 1998;96-7:347-50.
9. Leyden JJ. Oral isotrcetinoin. Dermatology 1997;195(Suppl 1):29-33.
10. Plewig G, Kligman AM. Therapy, Antibiotics: tetracyclines and erythromycin. In: Plewig G, Kligman AM, editors. Acne and Rosacea. Berlin: Springer-Verlag; 1993. p. 611-23.
11. Nishijima S, Akamatsu M, Kurokawa I, Asada Y. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne. Dermatol 1994;21: 166-71.
12. Leyden JJ. Antibiotic resistant acne. Cutis 1976;17:593-6.
13. Crawford WW, Crawford IP, Stoughton RB, Cornell RC. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol 1979;72:187-90.
14. Eady EA, Jones CE, Tipper JL, Core JH, Cunliffe WJ, Layton AM. Antibiotic resistant Propionibacterium acnes: need for policies to modify antibiotic usage. Br Med J 1993; 306:555-6.
15. Cooper AJ. Systematic review of Propionibacterium acnes resistance to systemic antibiotics. Med J Aust 1998;169: 259-61.
16. Cunliffe WJ. Propionibacterium acnes resistance and its clinical relevance. J Dermatol Treatment 1995;6 Suppl 1:S3-S4.
17. Weber R, Nadal D, 1st die Antibiotikaresistenz übertragbar? Schweiz Ärztezeitung 1999;80:198-200.
18. Bolognia JL, Edelson RL. Spread of antibiotic-resistant bacteria from acne patients to personal contacts - a problem beyond the skin? Lancet 1997;350:971-3.
19. Hensby C, Cavey D, Bouclier M, Chatelus A, Algale D, Eustache J, et al. The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoid-like modulator of cell differentiation. Agents Actions 1990;29:56-8.
20. Wiegand VW, Cunliffe WJ, Wyss R, Revoisier C. Treatment of female patients with isotretinoin: What is the safe posttherapy contraceptive period? Clin Dermatol 2000, Vancouver, May 1996, abstract 155.
21. Newton J. How cost-effective is roaccutane? Dermatology 1997;195(Suppl 1):10-4.
22. Didierjean L, Carraux P, Grand D, Sass JO, Nau H, Saurat JH. Topical retinaldehyde increases skin content or retinoic acid and exerts biologic activity in mouse skin. J Invest Dermatol 1996;107:714-9.
23. Creidi P, Vienne MP, Ochonisky S, Lauze C, Turlier V, Lagarde JM, et al. Profilometric evaluation of photodamage after topical retinaldehyde and retinoic acid treatment. J Am Acad Dermatol 1998;39:960-5.
24. Bernard BA. Adapalene, a new chemical entity with retinoid activity. Skin Pharmacol 1993;6 Suppl 1:61-9.
25. Griffiths CE, Elder JT, Bernard BA, Rossio P, Cromie MA, Finkel LJ, et al. Comparison of CD271 (adapalene) and alltrans retinoid acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol 1993;101:325-8.
26. Brogdan RN, Goa KL. Adapalene. Drugs 1997;53:511-9.
27. Diamanti-Kandarakis E, Tolis G, Duleba AJ. Androgens and therapeutic aspects of antiandrogens in women. J Soc Gynecol Invest 1995;2:577-92.